What's in West Penn Allegheny Health System's pipeline?

West Penn Allegheny Health System has 7 drugs in our index: 7 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with West Penn Allegheny Health System's portfolio?

Top competitors by shared drug class: California Allergy and Asthma Medical Group, Inc., Chiesi Farmaceutici S.p.A., Dey, Fujian Medical University Union Hospital, GlaxoSmithKline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/west-penn-allegheny-health-system.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

West Penn Allegheny Health System — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

West Penn Allegheny Health System pipeline: 7 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

7 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Budesonide, Fluticasone, Beclomethasone	Budesonide, Fluticasone, Beclomethasone	marketed
Normal saline with epinephrine	Normal saline with epinephrine	marketed	Sympathomimetic amine / Vasopressor	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors	Emergency Medicine / Critical Care
Fluticasone, Beclomethasone, Budesonide	Fluticasone, Beclomethasone, Budesonide	marketed
Beclomethasone, Budesonide, Fluticasone	Beclomethasone, Budesonide, Fluticasone	marketed
Beclomethasone, Fluticasone, Budesonide	Beclomethasone, Fluticasone, Budesonide	marketed	Inhaled corticosteroid	Glucocorticoid receptor	Respiratory/Pulmonology
Budesonide, Beclomethasone, Fluticasone	Budesonide, Beclomethasone, Fluticasone	marketed	Inhaled corticosteroid	Glucocorticoid receptor	Respiratory/Pulmonology
Fluticasone, Budesonide, Beclomethasone	Fluticasone, Budesonide, Beclomethasone	marketed	Inhaled corticosteroid	Glucocorticoid receptor	Respiratory / Pulmonology

Therapeutic area mix

Respiratory/Pulmonology · 2
Emergency Medicine / Critical Care · 1
Respiratory / Pulmonology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

California Allergy and Asthma Medical Group, Inc. · 1 shared drug class
Chiesi Farmaceutici S.p.A. · 1 shared drug class
Dey · 1 shared drug class
Fujian Medical University Union Hospital · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Imperial College London · 1 shared drug class
Intech Biopharm Ltd. · 1 shared drug class
AstraZeneca · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for West Penn Allegheny Health System:

Cite this brief

Drug Landscape (2026). West Penn Allegheny Health System — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/west-penn-allegheny-health-system. Accessed 2026-05-17.